Review
Open access
Oct 2026
Sleep and circadian disturbances in Alzheimer’s disease: clinical assessment, treatable syndromes, and limits of biomarker inference
Sleep and circadian disturbances in Alzheimer’s disease (AD) affect patients and caregivers, but clinical action depends on the syndrome, measurement, and outcome under consideration. This narrative review links sleep assessment to indication-based care while distinguishing symptomatic benefit, physiological target eng...
Xue-Yi Gan, Xi-Lin Zhou, Shuo-Lan Yan et al.
· Frontiers in Neurology · 0 citations